Company name
Santhera Pharmaceuticals
Company profile
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on developing and commercializing innovative medicines for rare neuromuscular diseases with high unmet medical need. Santhera holds an exclusive worldwide license from ReveraGen to AGAMREE® (vamorolone), a dissociative steroid investigated in DMD as an alternative to corticosteroids. AGAMREE is approved for DMD in the U.S., EU, UK, China, Hong Kong, and Canada.
Date, time and room information
Monday, May 4, 17:00 - 17:15, room Sydney
Category
Commercial stage company
Speaker information
| Name | Position | Institution |
|---|---|---|
| Catherine Isted | CFO | Santhera Pharmaceuticals (Switzerland) Ltd |
Further information for the sponsor website
